Insofar as they show exaggerated innate immune responses but are not overtly suffering from autoimmunity or inflammatory disease, pharmacologic inhibition of N4BP1 might have useful applications, for example, in the improvement of vaccine responses or as an adjunct to checkpoint inhibitors in the treatment of neoplastic diseases. The gene discussed is N4BP1; the disease is Autoimmunity.